Follow
Samy Morad
Title
Cited by
Cited by
Year
Ceramide-orchestrated signalling in cancer cells
SAF Morad, MC Cabot
Nature Reviews Cancer 13 (1), 51-65, 2013
6902013
Tirucallic acids are novel pleckstrin homology domain-dependent Akt inhibitors inducing apoptosis in prostate cancer cells
AC Estrada, T Syrovets, K Pitterle, O Lunov, B Büchele, ...
Molecular Pharmacology 77 (3), 378-387, 2010
1052010
Acid ceramidase is upregulated in AML and represents a novel therapeutic target
SF Tan, X Liu, TE Fox, BM Barth, A Sharma, SD Turner, A Awwad, ...
Oncotarget 7 (50), 83208, 2016
822016
Tamoxifen regulation of sphingolipid metabolism—therapeutic implications
SAF Morad, MC Cabot
Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2015
752015
Novel off-target effect of tamoxifen—inhibition of acid ceramidase activity in cancer cells
SAF Morad, JC Levin, SF Tan, TE Fox, DJ Feith, MC Cabot
Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2013
742013
Ceramide–antiestrogen nanoliposomal combinations—novel impact of hormonal therapy in hormone-insensitive breast cancer
SAF Morad, JC Levin, SS Shanmugavelandy, M Kester, G Fabrias, ...
Molecular cancer therapeutics 11 (11), 2352-2361, 2012
542012
Tamoxifen magnifies therapeutic impact of ceramide in human colorectal cancer cells independent of p53
SAF Morad, JP Madigan, JC Levin, N Abdelmageed, R Karimi, ...
Biochemical pharmacology 85 (8), 1057-1065, 2013
482013
A novel semisynthetic inhibitor of the FRB domain of mammalian target of rapamycin blocks proliferation and triggers apoptosis in chemoresistant prostate cancer cells
SAF Morad, M Schmid, B Büchele, HU Siehl, M El Gaafary, O Lunov, ...
Molecular pharmacology 83 (2), 531-541, 2013
462013
Gaucher's disease and cancer: a sphingolipid perspective
BM Barth, SS Shanmugavelandy, DM Tacelosky, M Kester, SAF Morad, ...
Critical Reviews™ in Oncogenesis 18 (3), 2013
382013
Acid ceramidase promotes drug resistance in acute myeloid leukemia through NF-κB-dependent P-glycoprotein upregulation
SF Tan, W Dunton, X Liu, TE Fox, SAF Morad, D Desai, K Doi, ...
Journal of lipid research 60 (6), 1078-1086, 2019
332019
Ceramide-tamoxifen regimen targets bioenergetic elements in acute myelogenous leukemia1
SAF Morad, TE Ryan, PD Neufer, TN Zeczycki, TS Davis, MR MacDougall, ...
Journal of lipid research 57 (7), 1231-1242, 2016
312016
Potential role of acid ceramidase in conversion of cytostatic to cytotoxic end-point in pancreatic cancer cells
SAF Morad, MC Messner, JC Levin, N Abdelmageed, H Park, AH Merrill, ...
Cancer chemotherapy and pharmacology 71, 635-645, 2013
312013
Modification of sphingolipid metabolism by tamoxifen and N-desmethyltamoxifen in acute myelogenous leukemia—impact on enzyme activity and response to cytotoxics
SAF Morad, SF Tan, DJ Feith, M Kester, DF Claxton, TP Loughran Jr, ...
Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2015
302015
(8 R)-3β, 8-Dihydroxypolypoda-13 E, 17 E, 21-triene Induces Cell Cycle Arrest and Apoptosis in Treatment-Resistant Prostate Cancer Cells
SAF Morad, C Schmidt, B Büchele, B Schneider, M Wenzler, T Syrovets, ...
Journal of natural products 74 (8), 1731-1736, 2011
302011
Bioactive sphingolipids in cancer biology and therapy
YA Hannun, C Luberto, C Mao, LM Obeid
Springer International Publishing, 2015
292015
Chemotherapy selection pressure alters sphingolipid composition and mitochondrial bioenergetics in resistant HL-60 cells
LP Kao, SAF Morad, TS Davis, MR MacDougall, M Kassai, ...
Journal of lipid research 60 (9), 1590-1602, 2019
252019
Role of P-glycoprotein inhibitors in ceramide-based therapeutics for treatment of cancer
SAF Morad, TS Davis, MR MacDougall, SF Tan, DJ Feith, DH Desai, ...
Biochemical pharmacology 130, 21-33, 2017
252017
Oleanolic acid methyl ester, a novel cytotoxic mitocan, induces cell cycle arrest and ROS-Mediated cell death in castration-resistant prostate cancer PC-3 cells
N Abdelmageed, SAF Morad, AA Elghoneimy, T Syrovets, T Simmet, ...
Biomedicine & Pharmacotherapy 96, 417-425, 2017
232017
Short-chain ceramides depress integrin cell surface expression and function in colorectal cancer cells
SAF Morad, LC Bridges, ADA Larrea, AL Mayen, MR MacDougall, ...
Cancer letters 376 (2), 199-204, 2016
202016
The onus of sphingolipid enzymes in cancer drug resistance
SAF Morad, MC Cabot
Advances in Cancer Research 140, 235-263, 2018
192018
The system can't perform the operation now. Try again later.
Articles 1–20